Dr. Rekhtman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-5900
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Cytopathology, 2007 - 2008
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2002 - 2006
Albert Einstein College of MedicineClass of 2002
Certifications & Licensure
NJ State Medical License 2024 - 2025
NY State Medical License 2007 - 2025
MD State Medical License 2006 - 2007- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 510 citationsThe 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.Andrew G. Nicholson, Ming-Sound Tsao, Mary Beth Beasley, Alain C. Borczuk, Elisabeth Brambilla
Journal of Thoracic Oncology. 2021-11-19 - 23 citationsInvasive Mucinous Adenocarcinomas with Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular ProfilingSoo-Ryum Yang, Jason C. Chang, Charles Leduc, Kay See Tan, Snjezana Dogan
Journal of Thoracic Oncology. 2021-07-01 - 2879 citationsComprehensive genomic characterization of squamous cell lung cancersPeter S. Hammerman, Doug Voet, Michael S. Lawrence, Douglas Voet, Rui Jing
Nature. 2012-09-27
Journal Articles
- PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung CancersG J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
- Pathologic Features of Response to Neoadjuvant Anti-PD-1 in Resected Non-Small Cell Lung Carcinoma: A Proposal for Quantitative Immune-Related Pathologic Response Crit...J M Isbell, N Rekhtman, J D Wolchok, J E Chaft, Annals of Oncology
Press Mentions
MSK Researchers Discover New Type of SCLCSeptember 18th, 2024- Memorial Sloan Kettering Identifies New Lung CancerSeptember 12th, 2024
- New, Rare Type of Small Cell Lung Cancer IdentifiedSeptember 11th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
